Staminflux Fast Tablets

The natural remedy for the functionality of the microcirculation The particular composition based on titrated and standardized plant extracts and on tri-layered tablet formulation, gives to Staminflux ® Fast a rapid and prolonged action on the functionality of the microcirculation. Thanks to the special tri-layered tablet, the release of the functional substances takes place at different times. Staminflux ® Fast exploits a new MICRONIZED DIOSMINE , the µSMIN ® Plus (registered trademark of bioavailable micronized diosmin and flavonoids). µSMIN ® Plus is 9 times more bioavailable than standard micronized diosmin, as demonstrated in a recent clinical study in healthy volunteers 1 .Full study results available at: https://www.mdpi.com/1420-3049/23/9/2174/htmμ smin ® Plus resulted effective in chronic venous insufficiency (CVI). In this study 2 , 72 CVD subjects with a CEAP (Clinical Etiology Anatomy Pathophysiology) classification system between C2 and C4b, were treated with μ smin ® Plus (diosmine dosage corresponding to 450 mg/die) for 8 weeks The study demonstrated:a reduction in CVD symptoms (varicose veins, edema, hardening of skin and inflammation) of -48.3% a reduction in pain of the legs of -41,96% ; a reduction in the leg circumference of -1.88 cm ; an increase in the Global Index Score (referred to quality of life) of + 44.4 %.Full study results available at: https://www.mdpi.com/2072-6643/13/3/999/htm* µsmin ® Plus is a registered trademark of Giellepi S.p.A. ItalyREFERENCES:Russo R et al., Comparative Bioavailability of Two Diosmin Formulations after Oral Administration to Healthy Volunteers. Molecules 23 (2018) 2174. Serra R, et al., Efficacy of a Low-Dose Diosmin Therapy on Improving Symptoms and Quality of Life in Patients with Chronic Venous Disease: Randomized, Double-Blind, Placebo-Controlled Trial. Nutrients. 2021 Mar 19;13(3):999.